4.8

CVE-2023-2836

Exploit

CRM Perks Forms <= 1.1.1 - Authenticated (Admin+) Stored Cross-Site Scripting

CRM Perks Forms <= 1.1.1 - Authenticated (Admin+) Stored Cross-Site Scripting

The CRM Perks Forms plugin for WordPress is vulnerable to Stored Cross-Site Scripting via form settings in versions up to, and including, 1.1.1 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with administrator-level permissions and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. This only affects multi-site installations and installations where unfiltered_html has been disabled.
Mögliche Gegenmaßnahme
CRM Perks Forms – WordPress Form Builder: Update to version 1.1.2, or a newer patched version
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
CrmperksCrm Perks Forms SwPlatformwordpress Version <= 1.1.1
Weitere Schwachstelleninformationen
SystemWordPress Plugin
Produkt CRM Perks Forms – WordPress Form Builder
Version *-1.1.1
Zu dieser CVE wurde keine Warnung gefunden.
EPSS Metriken
Typ Quelle Score Percentile
EPSS FIRST.org 0.6% 0.442
CVSS Metriken
Quelle Base Score Exploit Score Impact Score Vector String
nvd@nist.gov 4.8 1.7 2.7
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:N
security@wordfence.com 4.4 1.3 2.7
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:C/C:L/I:L/A:N
CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

https://github.com/Don-H50/wp-vul/blob/main/CPF-xss-exploit.md
Third Party Advisory
Exploit
https://plugins.trac.wordpress.org/changeset/2917582/
Patch
https://www.wordfence.com/threat-intel/vulnerabilities/id/de11636b-a051-4e76-bc26-ed76f66fe0df?source=cve
Third Party Advisory
https://www.wordfence.com/threat-intel/vulnerabilities/id/de11636b-a051-4e76-bc26-ed76f66fe0df
Third Party Advisory